COVID-19 in a patient with severe asthma using mepolizumab

BACKGROUND: There is a lack of information about the course of coronavirus disease 2019 (COVID-19) in patients with severe asthma who were treated with biologics. Some reports indicated that treatment with benralizumab, dupilumab, and omalizumab in patients with severe asthma was not associated with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Allergy Asthma Proc
Hauptverfasser: Aksu, Kurtuluş, Yesilkaya, Selma, Topel, Musa, Turkyilmaz, Suleyman, Ercelebi, Dilek Cuhadar, Oncul, Ali, Kalkan, Ilkay Koca, Ates, Hale
Format: Artigo
Sprache:Inglês
Veröffentlicht: OceanSide Publications, Inc. 2021
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8133013/
https://ncbi.nlm.nih.gov/pubmed/33536114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2500/aap.2021.42.200125
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge